Ola Bratt

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. ncbi request reprint [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men]
    Ola Bratt
    Urologiska kliniken, Universitetssjukhuset i Lund
    Lakartidningen 105:524-8. 2008
  2. doi request reprint Effects of prostate-specific antigen testing on familial prostate cancer risk estimates
    Ola Bratt
    Department of Urology, Helsingborg Hospital, Helsingborg, Sweden
    J Natl Cancer Inst 102:1336-43. 2010
  3. doi request reprint Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden
    Ola Bratt
    Department of Urology, Helsingborg Hospital, Lund University, Sweden
    Scand J Urol Nephrol 44:384-90. 2010
  4. ncbi request reprint [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed]
    Ola Bratt
    Universitetsjukhuset i Lund
    Lakartidningen 104:3460-4. 2007
  5. ncbi request reprint What should a urologist know about hereditary predisposition to prostate cancer?
    Ola Bratt
    Department of Urology, University Hospital in Lund, Lund, Sweden
    BJU Int 99:743-7; discussion 747-8. 2007
  6. doi request reprint Psychiatric treatment in men with prostate cancer--results from a Nation-wide, population-based cohort study from PCBaSe Sweden
    Anna Bill-Axelson
    Department of Urology, University Hospital, Uppsala, Sweden
    Eur J Cancer 47:2195-201. 2011
  7. doi request reprint Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden
    Sigrid Carlsson
    Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Urol Nephrol 43:350-6. 2009
  8. doi request reprint Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden
    Anna Bill-Axelson
    Department of Urology, University Hospital, Uppsala, Sweden
    Eur Urol 57:390-5. 2010
  9. doi request reprint (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy
    Henrik Kjölhede
    Section of Urology, Department of Surgery, Vaxjo Hospital, Lund University, 351 85, Vaxjo, Sweden
    World J Urol 33:1749-52. 2015
  10. doi request reprint Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer
    Henrik Kjölhede
    Section of Urology, Department of Surgery, Växjö County Hospital, Lund University, Sweden
    BJU Int 110:1501-6. 2012

Detail Information

Publications26

  1. ncbi request reprint [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men]
    Ola Bratt
    Urologiska kliniken, Universitetssjukhuset i Lund
    Lakartidningen 105:524-8. 2008
  2. doi request reprint Effects of prostate-specific antigen testing on familial prostate cancer risk estimates
    Ola Bratt
    Department of Urology, Helsingborg Hospital, Helsingborg, Sweden
    J Natl Cancer Inst 102:1336-43. 2010
    ..Family history is a strong risk factor for prostate cancer. The aim of this study was to investigate whether increased diagnostic activity is related to the incidence of prostate cancer among brothers of men with prostate cancer...
  3. doi request reprint Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden
    Ola Bratt
    Department of Urology, Helsingborg Hospital, Lund University, Sweden
    Scand J Urol Nephrol 44:384-90. 2010
    ..To investigate the effects of prostate-specific antigen (PSA) testing of men without clinical signs of prostate cancer on the incidence of prostate cancer in Sweden...
  4. ncbi request reprint [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed]
    Ola Bratt
    Universitetsjukhuset i Lund
    Lakartidningen 104:3460-4. 2007
  5. ncbi request reprint What should a urologist know about hereditary predisposition to prostate cancer?
    Ola Bratt
    Department of Urology, University Hospital in Lund, Lund, Sweden
    BJU Int 99:743-7; discussion 747-8. 2007
  6. doi request reprint Psychiatric treatment in men with prostate cancer--results from a Nation-wide, population-based cohort study from PCBaSe Sweden
    Anna Bill-Axelson
    Department of Urology, University Hospital, Uppsala, Sweden
    Eur J Cancer 47:2195-201. 2011
    ..To explore whether the self-reported psychological distress among men with prostate cancer was to the extent that it required psychiatric treatment...
  7. doi request reprint Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden
    Sigrid Carlsson
    Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Urol Nephrol 43:350-6. 2009
    ..Radical prostatectomy (RP) is currently commonly performed, either within or outside large high-volume centres. The aim of this study was to assess the 30-day mortality rate after RP in Sweden...
  8. doi request reprint Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden
    Anna Bill-Axelson
    Department of Urology, University Hospital, Uppsala, Sweden
    Eur Urol 57:390-5. 2010
    ..The risk of suicide is increased among cancer patients including men with prostate cancer (PCa). However, whether this increased risk applies to men diagnosed subsequent to prostate-specific antigen (PSA) testing is not known...
  9. doi request reprint (18)F-choline PET/CT for early detection of metastases in biochemical recurrence following radical prostatectomy
    Henrik Kjölhede
    Section of Urology, Department of Surgery, Vaxjo Hospital, Lund University, 351 85, Vaxjo, Sweden
    World J Urol 33:1749-52. 2015
    ..The purpose was to determine what proportion of a well-defined cohort of hormone-naïve patients who were candidates for early salvage radiotherapy had (18)F-choline PET/CT findings suggesting metastases...
  10. doi request reprint Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer
    Henrik Kjölhede
    Section of Urology, Department of Surgery, Växjö County Hospital, Lund University, Sweden
    BJU Int 110:1501-6. 2012
    ....
  11. doi request reprint Simplified intraoperative sentinel-node detection performed by the urologist accurately determines lymph-node stage in prostate cancer
    Henrik Kjölhede
    Department of Surgery, Vaxjo Hospital, Lund University, Sweden
    Scand J Urol 49:97-102. 2015
    ..The objective was to determine whether intraoperative sentinel-node detection with a simplified protocol can accurately determine lymph-node stage in prostate cancer patients...
  12. pmc The Study of Active Monitoring in Sweden (SAMS): a randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer
    Ola Bratt
    Department of Urology, Helsingborg Hospital, Lund University, Sweden
    Scand J Urol 47:347-55. 2013
    ..This article describes the Study of Active Monitoring in Sweden (SAMS), which aims to improve those methods...
  13. doi request reprint Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL
    Sam Ladjevardi
    Department of Urology, University Hospital, Uppsala, Sweden
    BJU Int 111:381-8. 2013
    ..The present study confirms the importance of curative treatment for men with high-risk prostate cancer...
  14. doi request reprint Extended pelvic lymphadenectomy for prostate cancer: will the previously reported benefits be reproduced in hospitals with lower surgical volumes?
    Christian Lindberg
    Department of Urology, Lund University Hospital, Lund, Sweden
    Scand J Urol Nephrol 43:437-41. 2009
    ..However, these studies were from high-volume centres. This study investigated whether these results could be repeated in a hospital with lower surgical volume, more typical for the Nordic countries...
  15. ncbi request reprint Hereditary prostate cancer: clinical aspects
    Ola Bratt
    Unit for Urology, Helsingborg Hospital, Sweden
    J Urol 168:906-13. 2002
    ..We review the current epidemiological and genetic knowledge regarding hereditary prostate cancer, and outline its clinical implications...
  16. doi request reprint Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer
    Ola Bratt
    Department of Urology, Helsingborg Hospital, Lund University, Helsingborg, Sweden Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK Electronic address
    Eur Urol 68:53-8. 2015
    ..Many elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not receive radical treatment, despite the high mortality associated with conservative management...
  17. ncbi request reprint Psychological aspects of screening in families with hereditary prostate cancer
    Ola Bratt
    Unit for Urology, Helsingborg Hospital, Helsingborg, Sweden
    Scand J Urol Nephrol 37:5-9. 2003
    ..The aim of this study was to assess possible negative psychological effects of screening for prostate cancer in a high-risk population...
  18. ncbi request reprint [Palliative cancer care is an important part of urology. A study of the last year of life of patients who died because of urologic cancer]
    Ola Bratt
    Urologiska kliniken, Universitetssjukhuset i Lund
    Lakartidningen 99:765-7, 770. 2002
    ..Although many symptoms could have been alleviated outside hospital, the majority of patients needed specialised urological hospital care during their last year of life...
  19. ncbi request reprint The urologist's guide to low dose-rate interstitial brachytherapy with permanent seed implants for localized prostate cancer
    Ola Bratt
    Department of Urology, University Hospital Lund, SE 221 85 Lund, Sweden
    BJU Int 99:497-501. 2007
  20. ncbi request reprint [Comments on the PSA in primary health care: survey results in more "losers" than "winners"]
    Ola Bratt
    Lakartidningen 100:4014-5. 2003
  21. ncbi request reprint Geographical variation in incidence of prostate cancer in Sweden
    Par Stattin
    Department of Surgical and Perioperative Sciences, Urology and Andrology, Umea University Hospital, Umea, Sweden
    Scand J Urol Nephrol 39:372-9. 2005
    ..To investigate the geographical variation in prostate cancer incidence in Sweden, in particular the incidences of screening-detected tumours and curative treatment of prostate cancer...
  22. ncbi request reprint Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005
    Jan Adolfsson
    Oncological Centre, Karolinska University Hospital, CLINTEC, Karolinska Institute, Stockholm, Sweden
    Scand J Urol Nephrol 41:456-77. 2007
    ..The incidence of prostate cancer is rising rapidly in Sweden and there is a need to better understand the pattern of diagnosis, tumor characteristics and treatment...
  23. ncbi request reprint A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer
    Ola Bratt
    BJU Int 95:192. 2005
  24. ncbi request reprint The difficult case in prostate cancer diagnosis--when is a "diagnostic TURP" indicated?
    Ola Bratt
    Eur Urol 49:769-71. 2006
  25. ncbi request reprint Watching the face of Janus--active surveillance as a strategy to reduce overtreatment for localised prostate cancer
    Ola Bratt
    Eur Urol 50:410-2. 2006
  26. pmc Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer
    Kimmo J Savinainen
    Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere, Tampere, Finland
    Am J Pathol 160:339-45. 2002
    ..Thus, it is unlikely that treatment modalities relying on the overexpression of ERBB2 gene will be useful in treating prostate cancer...